Biohaven Pharmaceutical Holding Co Ltd (BHVN) — Long-term Investment Intensity
Biohaven Pharmaceutical Holding Co Ltd (BHVN) has a Long-term Investment Intensity of 7.4% as of September 2022. Long-term investments of $10.00 Million represent 7.4% of total assets of $135.65 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Biohaven Pharmaceutical Holding Co Ltd net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Biohaven Pharmaceutical Holding Co Ltd Long-term Investment Intensity (2020–2021)
This chart shows how Biohaven Pharmaceutical Holding Co Ltd's Long-term Investment Intensity has evolved across 2 annual periods from 2020 to 2021. As of September 2022, the intensity stands at 7.4%, reflecting long-term investments of $10.00 Million against total assets of $135.65 Million USD. Also explore Biohaven Pharmaceutical Holding Co Ltd asset portfolio for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Biohaven Pharmaceutical Holding Co Ltd (2020–2021)
The table below presents the year-by-year Long-term Investment Intensity for Biohaven Pharmaceutical Holding Co Ltd from 2020 to 2021, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Biohaven Pharmaceutical Holding Co Ltd (BHVN) total market value.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 4.2% | $6.00 Million | $142.06 Million | ▼ -2.2 pp |
| 2020 | 6.4% | $7.18 Million | $111.50 Million | — |